Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FXS5626 in Active Non-infectious Uveitis
NCT07552012Phase 2Recruiting
- Sponsor
- Fosun Pharma
- Start
- Jan 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 2 trial of FXS5626 in noninfectious uveitis (NIU), sponsored by Fosun Pharma. Started Jan 2026; status: recruiting.
02
Drugs
FXS5626
03
Conditions
noninfectious uveitis (NIU)
Beyond the preview
Go deeper on NCT07552012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07552012.